Lai Quintin J 4
4 · WEST PHARMACEUTICAL SERVICES INC · Filed Aug 15, 2023
Insider Transaction Report
Form 4
Lai Quintin J
VP Corp Development & Strategy
Transactions
- Exercise/Conversion
Common Stock
2023-08-11$89.64/sh+8,772$786,322→ 27,078.93 total - Exercise/Conversion
Common Stock
2023-08-11$102.51/sh+7,140$731,921→ 34,218.93 total - Exercise/Conversion
Common Stock
2023-08-11$173.22/sh+3,348$579,941→ 37,566.93 total - Exercise/Conversion
Common Stock
2023-08-11$274.29/sh+1,388$380,715→ 38,954.93 total - Exercise/Conversion
Common Stock
2023-08-11$369.13/sh+453$167,216→ 39,407.93 total - Sale
Common Stock
2023-08-11$394.62/sh−10,725$4,232,326→ 28,682.93 total - Sale
Common Stock
2023-08-11$395.54/sh−8,635$3,415,510→ 20,047.93 total - Sale
Common Stock
2023-08-11$396.12/sh−1,741$689,650→ 18,306.93 total - Exercise/Conversion
Stock Options (Right to Buy)
2023-08-11−3,348→ 1,116 totalExercise: $173.22From: 2021-02-18Exp: 2030-02-18→ Common Stock (3,348 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2023-08-11−8,772→ 0 totalExercise: $89.64From: 2019-02-20Exp: 2028-02-20→ Common Stock (8,772 underlying) - Exercise/Conversion
Stock Options (Right to buy)
2023-08-11−7,140→ 0 totalExercise: $102.51From: 2020-02-19Exp: 2029-02-19→ Common Stock (7,140 underlying) - Exercise/Conversion
Stock Options (Right to buy)
2023-08-11−1,388→ 1,388 totalExercise: $274.29From: 2021-02-23Exp: 2031-02-23→ Common Stock (1,388 underlying) - Exercise/Conversion
Stock Options (Right to buy)
2023-08-11−453→ 1,359 totalExercise: $369.13From: 2023-02-22Exp: 2032-02-22→ Common Stock (453 underlying)
Footnotes (7)
- [F1]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $393.97 to $394.96, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F2]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $394.97 to $395.93, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F3]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $395.97 to $396.45, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F4]This option is fully vested.
- [F5]This award vests in four equal annual installments beginning on February 18, 2021.
- [F6]This award vests in 4 equal annual installments beginning on 2/23/2022.
- [F7]This award vests in four equal annual installments beginning on February 22, 2023.